These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28934384)

  • 1. SHORT syndrome due to a novel de novo mutation in PRKCE (Protein Kinase Cɛ) impairing TORC2-dependent AKT activation.
    Alcantara D; Elmslie F; Tetreault M; Bareke E; Hartley T; ; Majewski J; Boycott K; Innes AM; Dyment DA; O'Driscoll M
    Hum Mol Genet; 2017 Oct; 26(19):3713-3721. PubMed ID: 28934384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature.
    Petrovski S; Parrott RE; Roberts JL; Huang H; Yang J; Gorentla B; Mousallem T; Wang E; Armstrong M; McHale D; MacIver NJ; Goldstein DB; Zhong XP; Buckley RH
    J Clin Immunol; 2016 Jul; 36(5):462-71. PubMed ID: 27076228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.
    Thauvin-Robinet C; Auclair M; Duplomb L; Caron-Debarle M; Avila M; St-Onge J; Le Merrer M; Le Luyer B; Héron D; Mathieu-Dramard M; Bitoun P; Petit JM; Odent S; Amiel J; Picot D; Carmignac V; Thevenon J; Callier P; Laville M; Reznik Y; Fagour C; Nunes ML; Capeau J; Lascols O; Huet F; Faivre L; Vigouroux C; Rivière JB
    Am J Hum Genet; 2013 Jul; 93(1):141-9. PubMed ID: 23810378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in PIK3R1 cause SHORT syndrome.
    Dyment DA; Smith AC; Alcantara D; Schwartzentruber JA; Basel-Vanagaite L; Curry CJ; Temple IK; Reardon W; Mansour S; Haq MR; Gilbert R; Lehmann OJ; Vanstone MR; Beaulieu CL; ; Majewski J; Bulman DE; O'Driscoll M; Boycott KM; Innes AM
    Am J Hum Genet; 2013 Jul; 93(1):158-66. PubMed ID: 23810382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR complex 2 mediates Akt phosphorylation that requires PKCε in adult cardiac muscle cells.
    Moschella PC; McKillop J; Pleasant DL; Harston RK; Balasubramanian S; Kuppuswamy D
    Cell Signal; 2013 Sep; 25(9):1904-12. PubMed ID: 23673367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel PIK3R1 mutation of SHORT syndrome in a Chinese female with diffuse thyroid disease: a case report and review of literature.
    Sun L; Zhang Q; Li Q; Tang Y; Wang Y; Li X; Li N; Wang J; Wang X
    BMC Med Genet; 2020 Oct; 21(1):215. PubMed ID: 33129256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2.
    Chen CH; Sarbassov dos D
    J Biol Chem; 2011 Nov; 286(46):40386-94. PubMed ID: 21965657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.
    Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD
    J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation.
    Yang G; Murashige DS; Humphrey SJ; James DE
    Cell Rep; 2015 Aug; 12(6):937-43. PubMed ID: 26235620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure.
    Kwok A; Zvetkova I; Virtue S; Luijten I; Huang-Doran I; Tomlinson P; Bulger DA; West J; Murfitt S; Griffin J; Alam R; Hart D; Knox R; Voshol P; Vidal-Puig A; Jensen J; O'Rahilly S; Semple RK
    Mol Metab; 2020 Oct; 40():101020. PubMed ID: 32439336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APDS2 and SHORT Syndrome in a Teenager with PIK3R1 Pathogenic Variant.
    Ramirez L; Tamayo W; Ale H
    J Clin Immunol; 2020 Oct; 40(7):1020-1025. PubMed ID: 32778990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis.
    Liu P; Gan W; Inuzuka H; Lazorchak AS; Gao D; Arojo O; Liu D; Wan L; Zhai B; Yu Y; Yuan M; Kim BM; Shaik S; Menon S; Gygi SP; Lee TH; Asara JM; Manning BD; Blenis J; Su B; Wei W
    Nat Cell Biol; 2013 Nov; 15(11):1340-50. PubMed ID: 24161930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3R1 mutations in SHORT syndrome.
    Schroeder C; Riess A; Bonin M; Bauer P; Riess O; Döbler-Neumann M; Wieser S; Moog U; Tzschach A
    Clin Genet; 2014 Sep; 86(3):292-4. PubMed ID: 23980586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHORT syndrome in two Chinese girls: A case report and review of the literature.
    Zhang Y; Ji B; Li J; Li Y; Zhang M; Ban B
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1385. PubMed ID: 32602265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two.
    Bravo García-Morato M; García-Miñaúr S; Molina Garicano J; Santos Simarro F; Del Pino Molina L; López-Granados E; Ferreira Cerdán A; Rodríguez Pena R
    Clin Immunol; 2017 Jun; 179():77-80. PubMed ID: 28302518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant PIK3R1 mutations cause SHORT syndrome.
    Chung BK; Gibson WT
    Clin Genet; 2014 Mar; 85(3):228-9. PubMed ID: 24033310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome.
    Bárcena C; Quesada V; De Sandre-Giovannoli A; Puente DA; Fernández-Toral J; Sigaudy S; Baban A; Lévy N; Velasco G; López-Otín C
    BMC Med Genet; 2014 May; 15():51. PubMed ID: 24886349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.
    Liu P; Gan W; Chin YR; Ogura K; Guo J; Zhang J; Wang B; Blenis J; Cantley LC; Toker A; Su B; Wei W
    Cancer Discov; 2015 Nov; 5(11):1194-209. PubMed ID: 26293922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration.
    Razmara M; Monazzam A; Skogseid B
    Cell Commun Signal; 2018 Oct; 16(1):64. PubMed ID: 30285764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
    Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
    Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.